OLMA
Olema Pharmaceuticals Inc
2 super-investors hold OLMA worth a combined $28M. The largest position: Stanley Druckenmiller at 0.5% of their portfolio. This quarter the cohort logged 1 buy and 0 sells on the name. Cohort Conviction Score: 47 — ranked #64 of 724 scored stocks.
Why super-investors own OLMA
Stanley Druckenmiller initiated a new $15M position in OLMA in 2026Q1, representing 0.5% of his portfolio and marking the first time cohort interest has risen above one holder in eight quarters. Joel Greenblatt holds a $13M position at a negligible portfolio weight. Combined, the two owners represent $28M in exposure, with Druckenmiller's entry the clear signal event this quarter. At maximum 0.5% concentration, neither holding reflects high conviction by typical standards, though Druckenmiller's new stake is the sole activity driving any change in the cohort's profile. Broader super-investor interest in OLMA remains minimal.
AI-synthesized from 13F filings. Not investment advice.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Stanley Druckenmiller | 0.5% | — 1q | $15M | 986,827 |
| 2 | Joel Greenblatt | <0.1% | 22q | $13M | 905,332 |
Owners of OLMA also hold
Recent activity (1)
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller | NEW | 0.5% | +100% | $15M | May 15, 2026 |
Long US equity 13F-HR filings only. CUSIP 68062P106. Not investment advice.